Toggle navigation
Home
Search
Services
Blog
Contact
About
Sar Estimation of Skin and Eye Irritation and Toxicity S
Enslein, Kurt Nmi
Health Designs, Inc., Rochester, NY, United States
Search 9 grants from Kurt Enslein
Search grants from Health Designs, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer?s Symptomatic Expression: The INCREASE study
Cargo selectivity of the mammalian COPII coat complex
Pulmonary Surfactant Effects on the Macrophage Phenotype
Translocation of DNA Across the Agrobacterium Envelope
Parathyroid Hormone Receptors in Kidney and Bone
Recently added grants:
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease
A novel technology to assess chronic toxicity in genetically diverse nematode populations
In Vitro Toxicity Testing at Massive Scale in Diverse Primary Human Cells
BP-ENDURE at the University of Nevada
Develop pan-specific antibody against mutant glycyl-tRNA synthetase for treating CMT2D
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44ES004012-02A1
Application #
3507534
Study Section
(SSS)
Project Start
1985-09-10
Project End
1987-08-31
Budget Start
1985-09-10
Budget End
1986-08-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Health Designs, Inc.
Department
Type
DUNS #
City
Rochester
State
NY
Country
United States
Zip Code
14604
Related projects
NIH 1986
R44 ES
Sar Estimation of Skin and Eye Irritation and Toxicity S
Enslein, Kurt Nmi / Health Designs, Inc.
NIH 1985
R44 ES
Sar Estimation of Skin and Eye Irritation and Toxicity S
Enslein, Kurt Nmi / Health Designs, Inc.
Comments
Be the first to comment on Kurt Enslein's grant